TCL Archive Fox Chase Cancer Center plans $1 billion expansion that would double its size. October 22, 2004
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss June 5, 1981
TCL Archive In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman October 13, 1978
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012